text:
Using Drone-Sourced Mapping of the Entire Planet, ReROLL Promises to be the Ultimate Open-World Playground
Posted: 01:20PM
Author: ClayMeow
Last last year, Ubisoft's Julien Cuny and Louis-Pierre Pharand left Ubisoft Montreal to found their own independent studio called PIXYUL. Julien was Head of Content for Assassin's Creed, while Louis-Pierre was Creative Director and Head of UbiWorkshop. Today, PIXYUL announced its first game, the highly ambitious ReROLL.
According to PIXYUL, ReROLL is a "Crowdfunded Persistent Online Open World Survival Action RPG" – or as the announcement trailer puts it, "The Ultimate Open World Playground." What sets ReROLL apart from other games is that its environment is going to be sculpted based on real-world data. PIXYUL plans on drone-sourcing and mapping the entire planet, one square kilometer at a time. The drones are equipped with digital HD cameras and their data will be processed with 3D software to render into in-game terrain. If that sounds overly ambitious, it is. And that's why it won't be happening all at once and will be combined with procedural generation for certain parts of the world, such as the major oceans and restricted areas that will never be accessible to drones.
PIXYUL plans on starting with what its referring to as BRICK 1, though what region that entails hasn't been decided yet. What we do know is that BRICK 1 will not be in the United States because commercial drone use is not yet legal and won't be until sometime in 2015 when the FAA plans on establishing rules.
While the first stage of the game may be rather small in area, there are still two aspects of the game that are quite intriguing. The first is a system PIXYUL is calling Reality System Sync (RSS), which not only synchronizes the in-game time with the Coordinated Universal Time (UTC), but also pulls actual weather and temperature data and "injects" it into the game. For example, if your character decided to visit New York City right now, you'd be struggling to survive in the middle of a snow storm. I know because I have to shovel after writing this.
The second unique feature of the game is tied to the RSS. Because the in-game time is a direct 1:1 relation to real-world time, time is actually "a very important resource in the game." Even when you're not connected, your character remains "active" in the world. PIXYUL will be creating an Activity Tracker that you can access from a browser or smartphone, allowing you "to manage your character's schedule like you would manage your own agenda." As previously stated, ReROLL is a survival game, so a key strategy for survival will be "making sure your character is doing relevant things when you're not playing in front of your computer."
BRICK 1 is planned for mid-2015, but game packages are currently available for purchase on the official site, which will grant you lifetime access to ReROLL, starting with BRICK 1 when it's ready. Game packages range in price from $19.99 all the way up to $274.99. The way it works is that you are essentially buying a character (or multiple) to play as in the game world, each of which come with their own unique skills and starting gear. Depending on the amount of money you spend, you also get extra bonuses from "Gamers Angel Status" tiers. It's essentially PIXYUL's own version of crowd-funding, though the studio hasn't ruled out a Kickstarter or Indiegogo campaign in the future.
While buying different characters with different skills and gear may sound like a Pay2Win situation, PIXYUL ensures that that's not the case. For one, the game is not a free-to-play game. In addition, the game will feature no PvP, so there is technically no such thing as an "unfair advantage" – this is not like Rust or DayZ where you have to worry about other player characters. Lastly, and perhaps the most important part, is that nothing will be locked in the game – "You can start with a Basic Character and learn any skills and become whoever you want."
ReROLL is certainly an ambitious project and for all intents and purposes is just a pipe dream right now, but if PIXYUL can pull it off, it sounds like it could be a hell of a game. Be sure to watch the announcement video below to learn a little bit more and even see some early game footage.
Source: Press Release and Official Site


text:
by OhYeahBeliebers December 19, 2010
Justin Bieber was caught spoon swaggin and posted the pictures on Twitter. Him and this spoon have grown up together. They were seen on twitpic, and of course since they have been seen together, they MUST be dating.
spoon swaggin is the new thing
by belieber in love December 21, 2010
buy the domain for your art site

subset: commoncrawl


text:
Opens Barneys Warehouse in a new window
Opens The Window in a new window
Opens The Registry in a new window
Barneys Warehouse
Shop Designer Steals at Barneys Warehouse!
The Window
For Insider Fashion Access
The Registry
Barneys Warehouse
The Window
The Registry
Welcome to null
Please upgrade your version of Internet Explorer for your optimal viewing experience.
upgrade browser
continue to site
My Account
Personal Info
Address Book
Payment Options
My Orders
Email Preferences
My Favorites
My designers
Log Out
This product is currently unavailable.
Continue Shopping
Back to Top


text: TDK-Lambda Variable Programmable Power Supplies, Z+ Series - TDK-Lambda Z-100-6, The TDK-Lambda Z100-6 600W is a Z+ High-Density, 2U format, Bench-Top and Rack-Mountable Power Supply. The Z10-40 has been designed to meet the demands of a wide variety of ATE, laboratory and OEM applications, including test and measurement, semiconductor burn-in, component test, LED/Laser test, RF amplifiers, electromagnetic and electrochemical. This Z+ model can provide an output voltage from 0 to 100V DC and an output current between 0-6. The Z+ device is 33% smaller and 40% lighter than the previous generation (ZUP series) and similar products. The standard size is only 3.27 inches high by 2.76 inches wide, so up to 6 units can be installed in the optional 19 inch rack housing. This model has not been fitted for front panel output.Other applications include test and measurement, component test, laser diode, heater supplies, RF amplifiers and magnets.For details on the TDK-Lambda Z-NL100 19 inch Rack Housing (order code 55-3881). Please click HERE For details on the TDK-Lambda Z-NL200 Dual/ Triple Rack Housing (order code 55-3882). Please click HERE For details on a range of TDK-Lambda Z-232-9 Z-485-9 Serial Interface Cables, Please click HERE TDK-Lambda Z-100-6 Single Output Variable DC SM PSU Bench 0-100V 0-6A 600WCheck stock and price


text:
While the Bay Area economy remains robust, California has gotten stuck in a slowdown, according to the latest report from the closely watched UCLA Anderson Forecast. But it's not time to push the panic button.
The sluggish pace of the Golden State's recovery, caused in part by Washington's budget struggles and weak economies overseas, is temporary and doesn't signal a contraction or drastic slump, the report says.
"We began slowing down near the end of 2012, and that slowdown will last a while during 2013," said Jerry Nickelsburg, a senior economist with the Anderson Forecast. "You will be getting an upswing in jobs by the end of 2014 and into 2015."
The state's jobless rate, which was unchanged in December at 9.8 percent, is expected to average 9.6 percent in 2013, 8.4 percent in 2014 and 7.2 percent in 2015, Anderson projected.
Nickelsburg and other economists said the tech-oriented South Bay and the San Francisco-San Mateo-Marin regions will continue to enjoy robust job gains in the coming year or two. Recent gains have been strong enough to make Silicon Valley and San Francisco the two best employment markets in the entire country.
"That whole slow-recovery, sluggish-growth scenario doesn't apply in the Bay Area," said Jeffrey Michael, director of the Stockton-based Business Forecast Center at University of the Pacific.
"There is a long way to go in this tech boom and job boom in Silicon Valley," added Mark Vitner, a senior economist and managing director with San Francisco-based Wells Fargo Bank. "We are still in the early stages of this tech expansion, when you look at the demand for tablets, smartphones, social media, social gaming."
The South Bay added payroll jobs at an annual rate of 3.5 percent during 2012. That growth rate could jump to a 4 percent yearly pace during 2013, Vitner predicted.
"Job gains are occurring across a broad set of industries in the Bay Area now," Vitner said. "It's not just tech. Construction, leisure and hospitality are now stronger. Housing is getting stronger."
The Anderson Forecast predicted that nonfarm payroll growth in California will reach an annual rate of 1.4 percent in 2013, 2.1 percent in 2014 and 2.3 percent in 2015.
California's economy has reached an "inflection point," according to the UCLA researchers.
"We're moving toward a more solid recovery that will drive down the unemployment rate," Nickelsburg said. "The California economy is growing unevenly. But it continues to grow."
Contact George Avalos at 408-373-3556 or 925-977-8477. Follow him at twitter.com/george_avalos. ___


text:
5 Ways Woman Can Silence Their Inner Critics to Realize Career Success
As the saying goes, "you are your own worst enemy," and this is especially true for women in the working world. This type of thinking is what tends to hold women back from realizing the type of career success they want and deserve. We'll take a look at five ways women can confidently take on future opportunities in their careers by simply silencing their inner critics once and for all.


text:
- 7 whole graham crackers, broken into pieces
- 1/3 cup sugar
- 5 tablespoons unsalted butter, diced
- 3 (8-ounce) packages mascarpone cheese
- 1 cup sugar
- 3 tablespoons all purpose flour
- 3 large eggs
- 1/2 teaspoon vanilla extract
- 2 large peaches (about 1 pound), peeled, pitted, diced
- 1
- 1/2 cup balsamic vinegar
- 1/2 cup sliced peaches
Recipe Preparation
Preheat oven to 350°F. Blend graham cracker pieces, sugar, and butter in processor until moist clumps form. Press onto bottom (not sides) of 9-inch-diameter springform pan. Bake until golden brown, about 12 minutes. Transfer crust to rack to cool. Maintain oven temperature.
Using electric mixer, beat mascarpone, sugar, and flour in large bowl until blended. Beat in eggs 1 at a time; add vanilla extract. Puree diced peaches in mini processor or blender until smooth. Beat peach puree into batter. Pour filling into crust. Bake until edges are raised and dry and center is softly set, about 1 hour 5 minutes. Place hot cheesecake directly in refrigerator. Chill uncovered overnight.
Boil balsamic vinegar in small saucepan until reduced to 1/4 cup, about 4 minutes; cool syrup. Cut around cheesecake; remove pan sides. Top with peach slices, drizzle with balsamic vinegar syrup, and serve.


text:
Derry woman set to plead guilty to burglariesBy JAMES A. KIMBLE
Union Leader Correspondent
March 18. 2013 8:19PM
BRENTWOOD - A Derry woman has struck a plea deal with county prosecutors for her role in two burglaries that happened between last May and June.
Kristen Gile, 22, is expected to receive a 12-month county jail sentence in exchange for her guilty pleas in three cases now pending in superior court. Police first arrested Gile days after she allegedly burglarized her ex-boyfriend's home in Derry and stole his wallet last May 28.
Gile later attempted to use her ex-boyfriend's debit card at a local CVS store, and then tried to use the card to obtain money from an ATM last May 30, according to a police affidavit.
Derry police obtained store surveillance images from the CVS store that showed Gile attempting to use the card, a police affidavit said. Police also collected bank paperwork that showed four transactions in which she attempted to obtain money.
The boyfriend had reported the wallet as lost, but police found out about the burglary when a woman who drove Gile to the residence told them about the theft, police said.
Prosecutors say Gile also burglarized an acquaintance's home on June 6 shortly after visiting the home, and later sold a stolen ring at a local pawn shop around June 30.
Defense lawyers recently won permission from a judge to try the cases separately, arguing they were all unrelated incidents. Prosecutors did not object. Gile then struck a plea deal on all of the charges in those cases, court records say.
In addition to a year-long jail sentence, Gile would remain on probation for three years. She will have an additional 12-month sentence suspended as long as she remains on good behavior, according to terms of the deal. A judge will have to approve the plea deal. She is scheduled to enter her guilty plea on June 12. Had she been convicted at trial, Gile could have faced up to 3½ to 7 years in state prison on the felony charges.


text:
Peter B. "Bo" Rutledge
B.A., Harvard University
M.Litt., University of Aberdeen
J.D., University of Chicago
Civil Procedure
International Litigation
International Arbitration
International Business Transactions
Peter B. "Bo" Rutledge, the holder of the Herman E. Talmadge Chair of Law, became dean of the University of Georgia School of Law on January 1, 2015. Previously, he served as the associate dean for faculty development working closely with the law school's faculty, especially its untenured professors, to expand and promote scholarly activities.
Rutledge's teaching and research interests include international dispute resolution, arbitration, international business transactions and the U.S. Supreme Court.
He is the author of the book Arbitration and the Constitution and co-author with Gary Born of the book International Civil Litigation in United States Courts. His works have been published by the Yale University Press, the Oxford University Press and the Cambridge University Press, and his articles have appeared in a diverse array of journals such as The University of Chicago Law Review, the Vanderbilt Law Review and the Journal of International Arbitration. He also regularly advises parties on matters of international dispute resolution (litigation and arbitration).
In 2008, the U.S. Supreme Court appointed Rutledge to brief and argue the case of Irizarry v. United States as amicus curiae in defense of the judgment below. He subsequently won the case, joining the ranks of a select few advocates who have successfully defended a judgment below when the government refused to do so. Notably, he has served as a judicial clerk at the Supreme Court for Justice Clarence Thomas and at the U.S. Court of Appeals for the Fourth Circuit for Chief Judge J. Harvie Wilkinson III.
Given his interest in international dispute resolution, Rutledge has taught and spoken at numerous foreign universities. In 2010-11, he was a Fulbright Professor at the Institut für Zivilverfahrensrecht at the University of Vienna Law School. Foreign universities where Rutledge has been invited to speak include: Oxford University, Cambridge University, the University of Mainz, Jagiellonian University, Stockholm University and the University of Oslo.
An accomplished teacher, he has received several teaching awards, including most recently the 2016 John C. O'Byrne Memorial Award for Contributions Furthering Student-Faculty Relations.
In addition to his academic and legal work, Rutledge remains active in professional circles. He has advised parties on matters of international dispute resolution and has served as an expert in both litigation and arbitration. He is a listed arbitrator with several international organizations. He has testified on several occasions before Congress on pending arbitration legislation, has regularly spoken to broadcast and print media, and has given speeches to a range of professional audiences on matters such as international dispute resolution, arbitration and the Supreme Court.
Before entering the teaching academy, Rutledge practiced at Wilmer Cutler & Pickering (now Wilmer Cutler Pickering Hale and Dorr), where his practice included international dispute resolution and Supreme Court matters, and at Freshfields Bruckhaus Deringer, where his practice concentrated on international arbitration.
He holds a B.A. magna cum laude from Harvard University, an M.Litt. in Applied Ethics from the University of Aberdeen (Scotland) and a J.D. with high honors from the University of Chicago, where he served as executive editor of The University of Chicago Law Review and was inducted into the Order of the Coif.
Arbitration and the Constitution (Cambridge Univ. Press 2012).
International Civil Litigation in the United States, 5th ed. (Aspen 2011) (with Gary Born).
International Civil Litigation in the United States, 4th ed. (Aspen 2007) (with Gary Born).
Articles and Book Chapters
"From Custom to Cooperative Federalism: The Case of of Judicial Assistance Treaties in the United States" in Treaties in American Law, G. Fox and P. Dubinsky, eds. (Cambridge Univ. Press forthcoming).
"An Empirical Assessment of Arbitration Clauses in Credit Card Agreements" in Access to Civil Justice S. Estreicher Ed., (Cambridge Univ. Press, forthcoming).
The Testamentary Foundations of Commercial Arbitration, 30 Ohio St, J. on Disp. Resol. 275 (2015).
Arbitration, the Law Market and the Law of Lawyering, 38 Int'l Rev. L. & Econ. 87 (2014) (with E. O'Hara).
Sticky' Arbitration Clauses? The Use of Arbitration Clauses after Conception and Amex, 67 Vand. L. Rev. 955 (2014) (with C. Drahozal).
"Guerilla Tactics at Other International Institutions" in Guerilla Tactics in International Arbitration (G. Horvath ed.) (Kluwer 2013).
With Apologies to Paxton Blair, 45 N.Y.U. J. Int'l L. & Pol. 1063 (2013).
"The Proportionality Principles and the (Amount in) Controversy" in American Illness, (Yale Univ. Press, 2013).
"Forum Shopping in International Arbitration - Forum Non Conveniens and Lack of Personal Jurisdiction" in Forum Shopping in the International Commercial Arbitration Context (F. Ferrari ed.) (Sellier European Law Publishers, 2013).
Contract and Choice, 2013 BYU L. Rev. 1 (2013) (with C. Drahozal).
"Schiedsgerichte in Nordamericka" in Hamburger Handbuch des Exportrechts, 2nd ed. (2013) (with I. Hanefeld).
Toward a Functional Approach to the Sovereign Equality of Nations, 53 Va. J. Int'l L. 181 (2012).
Convergence and Divergence in International Dispute Resolution, 19 J. Disp. Res. 49 (2012).
"Zugang zum OGH aus Sicht der USA" in Der Zugang zum OGH in Zivil-und Strafsachen (Judicial Conference of the Supreme Court of Austria, forthcoming 2012).
Arbitration Clauses in Credit Card Agreements: An Empirical Study, 9 J. Empirical L. Studies 536 (2012) (with C. Drahozal).
TRIPS and BITS: An Essay on Compulsory Licenses, Expropriation, and International Arbitration, 13 N.C. J. L. & Tech. 149 (online ed.) (2012).
"Zugang zum Hoechstgericht aus Sicht der USA" in Zugang zum OGH in Zivil-und Strafsachen (Manz., 2012).
Contract and Procedure, 94 Marq. L. Rev. 1103 (2011) (with C. Drahozal).
Samantar, Official Immunity and Federal Common Law, 15 Lewis & Clark L. Rev. 589 (2011).
Samantar and Executive Power, 44 Vand. J. Transnat'l L. 885 (2011).
Arbitration and Kompetenz, 3 Y.B. Arb. & Mediation 217 (2011).
Decisional Sequencing, 62 Ala. L. Rev. 1 (2010).
Arbitrating Disputes Between Companies and Individuals: Lessons From Abroad, 65 Disp. Resol. J. 30 (2010) (with A. Howard).
Common Ground in the Arbitration Debate, 1 Y.B. Arb. & Mediation 1 (2009).
Arbitration Reform: What We Know and What We Need to Know, 10 Cardozo J. Conflict Resol. 579 (2009).
Introduction: The Constitutional Law of International Commercial Arbitration, 38 Ga. J. Int'l & Comp. L. 1 (2009).
Medellin, Delegation and Conflicts (of Law), 17 Geo. Mason L. Rev. 191 (2009).
"Schiedsgerichte in Nordamerika" in Hamburger Handbuch des Exportrechts (Dieckmann, 2009) (with Inka Hanefeld).
"United States Arbitration Law," in Practitioner's Handbook on International Arbitration, 2nd ed. (Oxford 2008) (with Rachael Kent and Christian Henel).
Who Can be Against Fairness: The Case Against the Arbitration Fairness Act, 9 Cardozo J. Conflict Res. 1201 (2008).
Whither Arbitration?, 6 Georgetown J. L & Pub. Pol'y 549 (2008).
Arbitration and Article III, 61 Vanderbilt L. Rev. 1189 (2008).
Discovery, Judicial Assistance and Arbitration: A New Tool for Cases Involving American Entities?, 25 J. Int'l. Arb.171 (2008).
Clerks, 74 U. Chi. L. Rev. 369 (2007).
"Post-Hague Hangover: Three Predictions About the Future of the Law Governing the Enforcement of Foreign Judgments and Arbitral Awards," in European Union Issues from a Portuguese Perspective (The Catholic University of America, Columbus School of Law 2007).
Market Solutions to Market Problems: Re-examining Arbitral Immunity as a Solution to Unfairness in Securities Arbitration, 26 Pace L. Rev. 113 (2005).
Miranda and Reasonableness, 32 Am. Crim. L. Rev. 1011 (2005).
Apprendi, Blakely and Federalism, 50 S.D. L. Rev. 427 (2005).
Toward a Contractual Approach to Arbitral Immunity, 39 Ga. L. Rev. 151 (2004).
An End of Term Exam: OT 2003 at the United States Supreme Court, 54 Cath. U. L. Rev. 151 (2004) (with Nicole Angarella).
The Standard of Review for the Voluntariness of a Confession on Direct Appeal in Federal Court, 63 U. Chi. L. Rev. 1311 (1996).
Other Publications
The Case Against the Arbitration Fairness Act, Dispute Resolution Magazine (Fall 2009).
What is the Definition of an "Organ" Under the Foreign Sovereign Immunities Act?, 34 Supreme Court Preview 351 (2007).
Termorio and the Problem of Local Standards Annulments , Transnational Dispute Management (Sept. 2006) (with Barney Ford).
Looking Ahead: October Term 2006, Cato Supreme Court Review 361 (2006).
Apprendi and Federalism, 18 Fed. Sent. Rep. 100 (Dec. 2004).
Review of Douglas Walton's Legal Argumentation and Evidence, 58 Rev. Metaphysics 208 (2004).
Private Modifications of the Ground for Judicial Review of Arbitral Awards: A Question of Institutions, 18 Mealey's Int'l Arb. Rep. 35 (Oct. 2003).
On the Importance of Institutions: Judicial Review of Arbitral Awards for Legal Errors, 19 J. Int'l Arb. 81 (Apr. 2002).
Supreme Court of the United States
- Briefed and Argued as Amicus Curiae appointed by the Supreme Court in successful defense of the judgment below in Irizarry v. United States, 76 U.S.L.W. 4401 (2008)
- Brief Amicus Curiae on behalf of the Chamber of Commerce of the United States of American in support of certiorari in Am. Isuzu Motors, Inc. v. Ntsebeza , 76 U.S.L.W. 3608 (2008)
- Brief Amicus Curiae on behalf of the Chamber of Commerce of the United States of America, the National Association of Manufacturers, and the American Chemistry Council in support of certiorari in Dow Chem. Co. v. United States, 127 S.Ct. 1251 (2007)
- Brief Amicus Curiae on behalf of the Chamber of Commerce of the United States of America , the National Association of Manufacturers in support of certiorari in Coltec Indus. v. United States, 127 S.Ct. 1261 (2007)
- Brief Amicus Curiae on behalf of the National League of Cities and the International Municipal Lawyers' Association in support of certiorari in City of Mesa v. Petersen, 543 U.S. 814 (2004)
- Petition for a writ of certiorari and reply brief in Fitzpatrick v. Missouri, 127 S.Ct. 729 (2006)
- Petition for a writ of certiorari and reply brief in Fuse v. United States, 544 U.S. 990 (2005)
Other Courts
- Brief Amicus Curiae for the National Foreign Trade Council, the Chamber of Commerce of the United States , the United States Council for International Business, the National Association of Manufacturers and the Organization for International Investment in the United States in Sinaltrainal v. Coca-Cola Co., 256 F. Supp. 2d 1345 (11th Cir. 2005)
- Brief Amicus Curiae for the National Association of Manufacturers and the Association of Equipment Manufacturers in FMS, Inc. v. Volvo, 349 F.3d 376 (7th Cir. 2003)
- Appellant's Brief, Reply Brief and Supplemental Brief on behalf of Appellant in Hairston v. United States (D.C. Cir.)
- Appellant's Brief, Reply Brief and Transfer Petition on behalf of Appellant in Fitzpatrick v. State, 193 S.W.3d 280 (Mo. App. 2006)
EXPERT WITNESS and CONSULTANT
- Senate Judiciary Committee, Subcommittee on the Constitution—Arbitration Fairness Act (December 2007)
- House Judiciary Committee, Subcommittee on Commercial and Administrative Law—Arbitration Fairness Act (October 2007)
Consultant Work
- Served as consulting expert for a major European corporation in an international commercial arbitration arising out of an investment in Eastern Europe
- Served as consulting expert for a major German telecommunications company concerning validity of service of process under Hague Service Convention and specialized federal statute governing non-resident patent holders.
- Served as consulting and testifying expert for an international business consortium concerning issues of sovereign immunity and diplomatic immunity.


text:
Since my ancestors on both sides migrated frequently around the mining communities of Northumberland I have often wondered if they bumped into each other on their travels. Today I came across documentary evidence of one such encounter and was intrigued to read a newspaper article about a quoit match involving my great granda from one side and two of my great granduncles from the other side. The Morpeth Herald of Saturday 6 April 1878 reports the results of the Quoit Handicap at Scotland Gate:
The full text of the article can be found here. Leonard Crackett is my paternal great grandfather. Andrew Oliver and Joseph Oliver are the younger brothers of my maternal great great grandmother Mary Oliver. None of my relatives actually won the competition.


text:
December 21, 2005
Several factors are being cited by Columbia Gorge Community College officials in connection with a 1.7 percent decline in fulltime student enrollment over the previous year.
Karen Carter, dean of student services, advised the college's fulltime equivalent (FTE) enrollment was 961.77 for the 2004-05 year. Total FTE was 978.66 in 2003-04, which was also down from the college's peak FTE of 1,054.53 in 2002-03. Enrollment had risen steadily up to that point, from 677.18 in 1994-95, when the college moved to its central campus in The Dalles.
"I am always concerned about a drop in enrollment, but there are some factors that lead me to be optimistic that this is a short-term trend," Carter said.
Various issues influence enrollment. The 2002-03 surge reflected a large influx of displaced workers following the shutdown of the aluminum industry in The Dalles. That was followed by declining state revenues, which forced the college to limit the number of courses offered.
More recently, according to Carter, "the cost of attendance has been growing faster than the availability of financial aid resources."
But she said there's good news on this front.
"This past legislative system changes were enacted in the Oregon Opportunity Grant, which should allow these funds to reach more students." That should help more students afford community college, Carter believes.
Carter notes that Oregon's community college system witnessed an overall FTE decline of 1.3 percent in 2004-05, very close to Columbia Gorge Community College's drop of 1.7 percent.
Another contributing factor, she continued, was a legislative move to reduce its reimbursement for adult continuing education courses; the college offered fewer of these courses as a result, which also hurt FTE.
Finally, the college has seen a significant increase in FTE in Hood River, following last year's opening of a college center in that city. (The college will start construction next year of a larger, permanent campus in Hood River.)
While that's been good for Hood River enrollment, Carter suggests it has reduced some enrollment at The Dalles campus, as fewer students travel here from Hood River.
Total Wasco County FTE was 763.39, down from 826.87 the previous year, while total Hood River County FTE was 198.55, an increase from 151.79 the previous year. (The year before that it was 219.16, but this relatively high figure reflects students attending classes in The Dalles prior to the college center opening in Hood River. FTE is tracked according to class locations, rather than students' county of residence.)
"I expect that as information about Columbia Gorge Community College and its programs and classes there becomes more widespread, we will see this demand increase," Carter said.
In the meantime, the college is taking other measures to increase enrollment, Carter said.
"First of all, we have been increasing our partnership with area high schools," she said. "We have academic advisers at Hood River Valley High School twice a month to meet with students regarding opportunities, both academically and financially, for their freshman year after graduation. We will begin this same experience at The Dalles Wahtonka High School in January."
The college has also launched its "Career Pathways" program, which is designed to bolster job skills over the short term, followed by continuing training for workplace advancement.
In addition, Carter said, the college's "Degree Partnership Programs" allow students to be enrolled both locally and at another Oregon college or university to meet specific degree requirements.
"Admissions and financial aid are handled jointly, making it an easy process for students to take advantage of opportunities at more than one school," Carter said. The local college has degree partnership agreements with Oregon State University, Portland State University, Oregon Institute of Technology and Concordia University, and is working on comparable agreements with Marylhurst, Linfield and Pacific universities.
On-line instruction is another avenue the college is embracing, Carter said; recently, this has been augmented by the ability to register for classes on-line, one of many features established through the college's adoption of a new registration and accounting system developed by Rogue Community College.
On-line classes allow greater flexibility for students with families and jobs, Carter notes. "By next year, we will offer a complete Associate of Arts Oregon Transfer degree on-line," she said.
Other initiatives include outreach to the Latino population and workforce training, she added.
"We are trying to meet the needs of students within our resources of both funding and space, and trying to be responsive to their educational needs and expectations," Carter said.
Comments are subject to moderator review and may not appear immediately on the site. A user's first several comments must be manually approved by a moderator.
Please read our commenting policy before posting.
Use the comment form below to begin a discussion about this content.
Information from the News and our advertisers (Want to add your business to this to this feed?)


text:
A singleplayer mappack – a whole episode, but almost every map is made by a different mapper (beginners and experienced) without knowing the other maps, with only given entrance and exit areas, so that all the maps could be joined in one big episode.
Only registered members can share their thoughts. So come on! Join the community today (totally free - or sign in with your social account on the right) and join in the conversation.


text:
Frogs are hatched in water, where they live for a while as tadpoles. They then emerge onto land, after growing limbs and losing their tails, in a process known as metamorphosis. Some people regard metamorphosis as evidence of evolution, but the fact is that metamorphosis has nothing whatsoever to do with evolution.
The only developmental mechanism that the theory of evolution proposes is mutations. Metamorphosis, however, does not take place through such chance events, but these changes are already programmed in the frog's genetic data. In other words, when a tadpole is first hatched, it is already determined that it will eventually undergo a process of change and come into possession of a frog's body suited to life on land.
Recent research has shown that metamorphosis is a very complex process controlled by different genes. In this process, for example, during the disappearance of the tail alone, "more than a dozen genes increase their activity," according to the journal Science News.41
Evolutionist claims of a "transition from water to land run along the lines that fish with the genetic data for total life in water evolved by chance into terrestrial amphibians as a result of random mutations. For that reason, metamorphosis represents evidence that actually undermines evolution, rather than supporting it. The slightest error in the process of metamorphosis will leave an animal crippled or dead, so there can be no question of a random change. Metamorphosis must be completed in a flawless manner.
It is impossible to maintain that such a complex process, one that allows no margin of error, emerged through random mutations, as the evolution theory claims.
41."A surprising tale of a frog's tail- research into a tadpole's metamorphosis into a frog," Science News, July 17, 1999, p. 43.2009-08-15 17:37:42


text:
Other threads by me: * Journey through Evolution * Muslim call to Christians * Redirected arguments
This thread deals with the basics of Islam, and aims to dispel myths and misunderstandings. Please refrain from embedding pics and vids in this thread, to keep it clean and facilitate flow.
The main sources for this thread are Seekers and Qibla course materials, Masud's online aggregation, research conducted by RISSC English Publications, and lectures/material from the Zawiyah Institute in Walmer Estate, Cape Town.
Abdurahman Dollie


text:
DETROIT — Emanuel Steward, the owner of the legendary Kronk Gym and one of boxing's greatest trainers, has died. He was 68.
Victoria Kirton, Steward's executive assistant, says Steward died Thursday in a Chicago hospital. She did not disclose the cause of death.
The International Boxing Hall of Famer made his name training Thomas Hearns at the Kronk Gym in Detroit. That paved the way for Steward to work with a long line of champion boxers such as champion Lennox Lewis, during a big part of his title run, and current heavyweight champion Wladimir Klitschko as recently as July.
Steward owned the legendary Kronk Gym, where his fighters were clad in red and gold trunks, and worked as an analyst for HBO.


text:
Apr 13,2009
Ask Joe Weider: Shoulders can be widened -- with work
by Joe Weider
Tip of the Week: Want to burn fat and get your heart in shape? Lift weights!
Most people think of bodybuilding as an activity that will give you big muscles, maybe some strength, but not much else. Well, I've got news for them! Not only will bodybuilding training build muscle and create strength, but it'll also burn fat and even turn you into a fat-incinerating machine.
If you keep the rep range high (12 to 20) and keep the pace of your workouts quick (30 seconds or so between sets), you can keep your heart rate elevated and your fat stores being drawn upon for energy.
Not only that, but because muscle requires more energy to simply exist than does fat, once you have developed muscles you will burn more calories than you otherwise would. In other words, bodybuilding, when tailored to your specific needs, can be a win-win situation!
Q: Hi, Joe. I'm 19 years old, and I'm trying to get my shoulders as wide as possible. I'm 6 feet and 180 pounds, so I'm trying to put on about 20 pounds of muscle anyway. But beyond that, I want really wide shoulders. That looks impressive even in clothes. Problem is, it seems my shoulders structurally aren't very wide. So is there anything I can do to actually stretch them out and make them wider?
Joe: From the sounds of it, you have somewhat narrow clavicles. The clavicles are the curved bones that run across the top of your ribcage out nearly to the ends of your shoulders. Their length, or lack thereof, is the biggest factor when it comes to the width of one's shoulders, and unfortunately there's nothing you can do to grow them.
While this bit of news may disappoint you, what I will tell you next should hearten you. Just because you have narrow clavicles doesn't mean you're doomed to narrow shoulders. One of the all-time great bodybuilders who also happened to be the first Mr. Olympia, Larry Scott, also had narrow clavicles — but he didn't let that stand in his way of becoming the best bodybuilder in the world. Larry set himself to the task of building cantaloupe-sized deltoids at the ends of his clavicles and in time becoming known for his shoulder development.
Larry saw his narrow clavicles as a challenge, not as a defeat. Through focused and intense training, he managed to overcome his structural deficiency and become a champion. I encourage you to read about Larry and follow the routine he used to build his own shoulders. Just remember, Rome wasn't built in a day and neither were Larry's delts. With patience and persistence, you will reach your goals.
Q: I'm a 29-year-old woman and am in good shape. I exercise four to five times a week and on a good week six times. For me, exercising could include going to the gym, riding my bike 10 miles to and from work, jogging at night or taking yoga. I am mostly happy with my figure, but I think that my waist is too thick for my thighs and hips. I would like a nice curve there, but instead there's straight up and down. I'm fairly lean as it is, so how do I reduce my waist size?
Joe: If, as you say, you are already lean, you might consider if you're doing too much in the way of abdominal exercises. Although it sounds like your exercise regimen is well-rounded and not too focused on any one aspect, it is possible that your abdominal muscles are highly receptive to stimulus and therefore grow faster than other muscle groups. In this case, you would want to scale back your abdominal training, especially the obliques, which are the muscles running along your sides.
If, however, you are not emphasizing abs in your training, I would suggest you try working your gluteals and outer thighs to create the curves you seek. While you wouldn't be reducing your waist, you would be creating a visual cue that would make your waist appear smaller to the eye. Narrow-stance squats, leg presses with your toes pointing slightly inward and stiff-legged deadlifts all work the areas that can create a nice flow from waist to thigh.
Joe Weider is acclaimed as "the father of modern bodybuilding" and the founder of the world's leading fitness magazines, including Shape, Muscle and Fitness, Men's Fitness, Fit Pregnancy, Hers, Golf for Seniors and others published worldwide in over 20 languages.


text:
Gambit Streaming In HDFull Gambit Movie HD with duration 120 Min and released on 2016-10-06 with MPAA rating is 6.
- Original Title : Gambit
- Movie title in your country : Gambit
- Year of movie : 2016
- Genres of movie : Fantasy, Action, Science Fiction,
- Status of movie : Planned
- Release date of movie : 2016-10-06
- Companies of movie : Genre Films, Free Association,
- Countries of movie : United States of America,
- Language of movie : English,
- Durationof movie : 120 Min
- Average vote of movie : 8.8
- Youtube ID of movie :
- Translation of movie : EN,DE,ES,FR,
- Cast of movie :
- Channing Tatum ( Remy LeBeau / Gambit )
Gambit Synopsis:
Full Streaming Gambit Channing Tatum stars as Remy LeBeau, aka Gambit, the Cajun Mutant with a knack for cards. Movie Gambit Full Duration
Gambit Enjoy Movie streaming movie in HD without downloading, Enjoy Movie Gambit Full online movie streaming free and fun Gambit Free Movie Stream only here Today, we can see that hundreds thousands of people looking for free Gambit and watch it on their sweat house with internet connection. Be happy, you can reach hundreds of thousands of satisfied members who became tired of waiting for DVDs in the mail, and now you can watch for free Gambit Film, get some free new movie online free watch and download new movie new releases and the hottest classics on our site. It is fast. It is easy. And best of all, it is free to try
Director : Rupert Wyatt, Screenplay : Joshua Zetumer, Characters : Chris Claremont, treatment : Chris Claremont
Yes, now you can Watch Movie Gambit Full Movie Streaming and get the link to Gambit In HD


text:
Gettin' Triggy Wit It
Unit 3: Formalizing Derivatives and Techniques for Differentiation
Lesson 9 of 21
Lesson 9 of 21
Objective: SWBAT compute derivatives of trig functions algebraically; SWBAT compute derivatives algebraically using the product and quotient rules.
Big Idea: With sketching derivative functions graphically and the quotient rule, students will discover the derivatives of the 6 trig functions.
Math, Derivatives, Precalculus and Calculus, Trigonometric functions, calculus ab, derivatives graphically, derivative rules, geogebra, calculus, AP Calculus, AP Calculus AB
60 minutes
Warm-up and Homework Review
30 min
Resources (3)
expand content
Setting the Stage
5 min
Resources (1)
expand content
22 min
Resources (2)
expand content
Closure + Homework
3 min
Resources (2)
expand content


text:
The Morning After
Let me start by saying a big thanks to Amy over at Circus Posterus who chose Halloween to post an interview with yours truly. Definitely one of the coolest online nods I've gotten this season.
The oddest? I made the list for Best Dating Sites "20 Sites to Plan the Perfect Halloween Date" which tickled me to no end. I'm at the bottom, for those who want to get crafty on their date. Hilariously awesome.
Now, who is going to hand out the "We Survived Halloween 2012" shirts?
Strange year. Ventured out into the city early yesterday evening and in neighbourhoods that traditionally overflowed with Halloween celebration and decoration, but there was little to be found. You'd think it was the start of October, not the end. Certainly not Halloween itself.
But people were in good spirits. I caught a matinee after work while waiting to meet with a friend, and the girl at the ticket counter was wearing impressive zombie makeup. So I gave her a mini chocolate bar from the stash in my purse. I was just as pleased to give it as she was to take it.
The rain sent folks scurrying to and fro. I watched as trick or treaters ran down the street without stopping for candy. Even though their night was cut short by the rain, the families all were grinning and laughing as they scampered through the wet leaves.
The highlight was the lone costumed figure leisurely sauntering down the street, wearing a white robe with red sash, numerous glowing necklaces, and a huge lizard (dinosaur?) head protected by the umbrella they held. It was one of those moments where I wished I had my camera on me, but also knew I wouldn't need a picture to remember it clearly.
From reports via social networking and blog posts, it would seem while our spirits (and decorations, and costumes) were dampened, they were not extinguished. In fact, I think Halloween folk and haunters still had a blast in their neck of the woods, the comfort of their homes, or by sharing Halloween goodies online with each other. A real sense of community. I like that.
The run-up to Halloween . . .
. . . certainly seemed quieter this year. But last night's turnout was good in spite of the weather. As if on cue, the wind and rain subsided for nearly two hours. And then it started to pour again. Hasn't stopped since! Happy Halloween! :O)
If memory serves, last year
If memory serves, last year was especially wet for a lot of Eastern Seaboard haunters too. This year it was a hurricane trying to douse the Halloween candle. As you say, going by comments from all over the Web I think a good time was still had by the majority. You can't keep a dedicated ghoul down.
The door-to-door TOT'ing in Canada and U.S. isn't done much here in England. But I saw lots of people out in costume over the weekend, going to parties at clubs and bars. No one out and about on Wednesday night, but I didn't expect to see anybody. I don't know about you, but I'm always a little sad come November 2nd, which is when I pack away the Halloween decorations for another year.
I would have loved to see Dinohead (Godzilla in fancy dress perhaps?) you describe.
Here's to next year!
Post new comment


text:
Dear Member
The site is on archive and further discussions are to be held on our Facebook page. Our FB page is popular with over 1.7 million likes and many more choose to discuss and post on threads on there.
See link https://www.facebook.com/pakistanPKaffairs
Any member who wishes to be added as a FB editor may apply to us by contacting us and if deemed appropriate you will be added to allow you to post new threads on our FB page.
Best Wishes
Discussions on Domestic Indian Politics and Current Affairs
Corruption in Indian Army...
29th January 2016, 11:19
Dassault pitches Rafale M for...
13th February 2016, 10:42
LCA Tejas test-fires Derby...
6th February 2016, 06:26
IAF to procure 8 aerostat...
3rd February 2016, 09:15
Isro's next PSLV to carry...
18th January 2016, 19:20
Sticky Threads
Normal Threads
Use this control to limit the display of threads to those newer than the specified time frame.
Allows you to choose the data by which the thread list will be sorted.
Order threads in...
Note: when sorting by date, 'descending order' will show the newest results first.
Forum Rules


text:
Poet: Raymond Carver
Poem: Late Fragment
Added: Feb 20 2003
Viewed: 799 times
Poem of the Day:
Mar 27 2008
Do you have any comments, criticism, paraphrasis or analysis of this poem that you feel would assist other visitors in understanding this poem better? If they are accepted, they will be added to this page of American Poems. Together we can build a wealth of information, but it will take some discipline and determination.
Do not post questions, pleas for homework help or anything of the sort, as these types of comments will be removed. The proper place for questions is the poetry forum.
Please note that after you post a comment, it can take up to an hour before it is visible on the website! Rest assured that your comment is not lost, so don't enter your comment again.
Comment on: Late Fragment
By: Raymond Carver
Late Fragment
Last read:Aug 15 2018, 2:23AM
Poem of the Day:
Mar 27 2008
Viewed 799 times.
Added: Feb 20 2003
More Poems
(16 poems)
Raymond Carver books


text:
Sermons are listed below by date order, use the filter to help find a specific sermon, change the date order or just browse them all by scrolling down the page.
Please note: For Sermons listed that are more than two years old; the MP3 may no longer be available for download online, but may be obtained by contacting the St Marks Berowra office.
(new sermons that match this search)
(all new sermons)
Sermons (1)
|Noah - remembered
|Genesis 6:1-22 (Part of the Genesis series).
|Preached by Simon Elliott on February 8, 2014 (Family Service).


text:
Whitko back in action tonight
Whitko's baseball team, along with its softball team, will be in action tonight. The boys travel to Argos while the girls head in the other direction, facing Bluffton. Spring sports will be in full swing next week, as 38 varsity games are scheduled in the six-day span.


text:
We first heard of the Fremont people as we hiked to Lower Calf Creek Falls in the Grand Staircase Escalante region.The remains of their storage granaries perched at the edges of the high cliffs above us, and we were thrilled to spot their painted rock art, "pictographs," on a distant canyon wall.
They also decorated many of the rock walls of Capitol Reef National Park to the east, but here the Freemont people carved into the cliff faces rather than painting upon them and created "petroglyphs."*
The Fremont culture farmed and hunted the Capitol Reef area from around 700 AD to 1250 AD. Their primitive art electrified our imaginations and created questions that can never be answered completely. Questions about ancient motivations and joys… about the death of a culture and the interpretation of its fragmented traces from centuries beyond.
*An easy way to remember the difference is to think: "paint a picture" for pictograph.
Updated from November 9, 2008.
More album photos: Heather Dugan Creative on Facebook


text:
Views of the National Parks (Views) is a multimedia education program that presents stories of the natural, historical, and cultural wonders associated with national parks, so all Americans can discover for themselves why national parks are special places.
Alternatively, you can visit the classic version of the program.
Views of the National Parks is a program of the National Park Service.


text:
Registered Nurse (RN) Supervisor - $5000 Sign On Bonus
- Employer
- Casa Bonita Convalescent Hospital
- Location
- San Dimas, CA, US
- Salary
- Competitve
- Posted
- Sep 16, 2017
- Closes
- Oct 17, 2017
- Ref
- 9e201f0e2
- Specialty
- Managerial
- Contract Type
- Permanent
Casa Bonita Convalescent Center is looking for an exceptional full-time Registered Nurse Supervisor to make a long term career servicing our residents for both the Skilled Nursing and Sub Acute departments. This compassionate individual is responsible for assuring physicians orders are followed and quality care is provided on each shift in a skilled care facility. This position involves 90% direct patient care and 10% administrative non-direct patient care. The Registered Nurse assists in providing a clean, safe, dignified, happy and healthy environment for residents by performing the duties as described below:
ESSENTIAL DUTIES AND RESPONSIBILITIES include the following. Other duties may be assigned.
Supervises LVNs and CNAs, carrying out all supervisory responsibilities in accordance with the organizations policies and applicable laws
Complies with the facilitys attendance policy requiring regular, reliable, and punctual attendance
Makes actual patient rounds, assessing and observing the following at least three times per day:
- Monitoring vital signs as necessary with appropriate interventions as indicated
- G-T / enteral feedings
- Vent
- Suctioning Needs
- Oxygen Needs
- Respiratory Needs
- Positioning
- Restraint application
- Hydration/nutritional status/feeding program
- Actual patient interviews
- Assessment of new admissions
- Pre/post-dialysis assessment
- Monitoring lab and x-ray values related to patients condition
- Incontinence and related interventions
- Skin care and/or changes of skin condition
- Use of proper assistive devices
- Ensures timely response to call lights
- Pacemaker check as ordered
- Acute changes in condition: nausea, diarrhea, infections, LOC changes, confusion, elevated temperature
- Respiratory Needs
- Pain management/intervention
- Assess behavior and provide interventions as indicated
- Wound treatments
- Therapy treatments
- Incidents; falls, unusual occurrences
- Patient complaints / concerns
- Abnormal laboratory values
- Identifies/assesses emergency medical situations and provides appropriate interventions as indicated
- Documentation and follow-up with timely notification of physician and family
- Care planning as needed
- Initiates within two weeks of admission of an incontinent resident, a written assessment by a licensed nurse to determine the patients ability to participate in a bowel and/or bladder management program.
- Creates an individualized plan, in addition to the patient care plan, for each resident in a bowel and/or bladder management program.
Makes comprehensive assessments and interventions related to changes of patient condition:
Evaluates patients for bowel and bladder program
Implements measures to prevent and reduce incontinence for residents, including:
Provides a weekly written evaluation in the progress notes by a licensed nurse of the residents performance in the bowel and/or bladder management program.
Intravenous Insertion, site changes, dressing changes, intravenous medication administration, assessing intravenous insertion site for s/s of infection and/or need for changes
RN may be assigned to administer medications and/or treatments if necessary
Establish and implement patient plans of care and document care provided appropriately
Ensures that Medicare guidelines, as well as HMO/PPO guidelines are within the facility Medicare change of condition documentation.
Performs administrative non-direct non-patient care as assigned by the DON and/or Administrator
Monitors condition changes and properly documents and follows-up as necessary.
Performs other duties or functions as assigned by the DON and/or Administrator
Supervises the LVNs and CNAs, carrying out all supervisory responsibilities in accordance with the organization's policies and applicable laws. Responsibilities include assigning, and directing work; appraising performance of LVNs; addressing complaints and resolving problems.
Current, unrestricted, verifiable California RN license. The nursing license must be maintained in a current status and provide evidence of renewal as required by the facilitys policies and procedures. Training in rehabilitative and restorative nursing practices preferred.
Current CPR Card
Current strong clinical skills with an emphasis on respiratory patients.
Knowledge of long-term care patient needs.
Requires mental maturity to deal with fast-paced work environment.
Must be able to cope with mental and emotional stress related to working with persons who are ill, disabled, elderly and/or emotionally upset, and/or memory impaired.
Must be able to manage resident behavior that includes verbal outbursts, combative behavior, striking out, and memory impairment.
Ability to speak Spanish or any other non-English language helpful but not required.
Must be aware of and understand the needs of the residents.
Medical/Dental/Vision/401K Match (F/T)
*Bonus paid out over the course of 1 year of employment


text:
My tomato plants are starting to produce tomatoes. I am about 2 weeks away from not having to buy"anemic" tomatoes. Next to strawberries, tomatoes are a fruit that I absolutely love. That's why I'm on a bruschetta kick. I keep basil growing in my backyard, for as long as the warm weather allows it to thrive. My version of bruschetta is very traditional-- Roma tomatoes, salt & pepper, finely minced garlic and fresh chopped basil. Sometimes I add balsamic vinegar, sometimes I don't. I brush olive oil on baguette slices and broil them for a minute; then rub a clove of fresh garlic. Heaven!
I rarely eat at chain food restaurants. If I do, I'll go to Applebee's and order their burgers. A while back, Tyler Florence created a bruschetta burger for Applebee's, but I don't think it's on the menu anymore (I think I haven't eaten there in over a year). I had a hankering for a grilled burger, and then I decided to create my own burger.
I kept the burger simple-- 80/20 fresh ground beef, salt & pepper. I was looking for ciabatta rolls (this summer, when I have more time, I will make my own), but I settled on fresh francesca rolls. I had slices of provolone cheese in my fridge, that was near the end of it's life (or I would have used mozzarella).
I bought locally grown salad greens, heirloom small tomatoes and I spotted some feta cheese in my fridge. I made my family favorite balsamic vinaigrette (minus the poppy seeds) that also pairs well with a strawberry spinach salad.
You can view all three printable recipe cards by scrolling to the end of this post.


text:
Your browser does not support iframes.
An item that appeared in last week's Police Beat should have said Christopher Crittenden. 26, of Jonesville, was charged with public intoxication/controlled substance at 3:58 a.m. Aug. 13. He was lodged in the Grant County Detention Center.
The News apologizes for the error.
Grant County Sheriff's Office
Deputy Lee Jacobs investigated an accident at 3 p.m. Aug. 12 on Warsaw Road. The drivers involved were John Kennedy, no age given, of Dry Ridge, driving a 2008 Dodge and Becky Clise, 36, of Dry Ridge, driving a 1997 Ford.
The following building permits were issued in Grant County in June and July 2009:
June 4:
Grant County Industrial Development Authority, amphitheater, 115 Baton Rouge Road, 2,016 sq. feet, estimated cost $97,000; permit fee $411.64
June 8:
Helen Roland Trust, new roof, 23 Taft Hwy., 1,104 sq. feet, estimated cost $5,000; permit fee $57.76
Rex Benson, temporary tent, 101 Spears Lane, 1,500 sq. feet; permit fee $35
Rex Benson, temporary tent, 11 Taft Hwy., 1,500 sq. feet; permit fee $35
Dry Ridge
Chief Rick Kells investigated an accident at 12:19 p.m. Aug. 8 on KY 22. The drivers involved were Anna M. Mills, 18, of Dry Ridge, driving a 1999 Chevrolet and Charles Asher, 62, of Dry Ridge, driving a 1992 Ford.
Deputy Lee Jacobs executed a Harrison County warrant for Christoper L. Annis, 24, of Corinth. The arrest occurred at 3:30 p.m. on Aug. 5 at the Grant County Detention Center.
The grand jury, which met Aug. 12, returned indictments against five people.
An indictment means there is probable cause to believe a crime has been committed; guilt or innocence is established later through the trial procedure.
Those indicted were:
• Tamela L. Gatewood, 42, with three counts trafficking in a controlled substance, first offense.
• Mischelle R. Mayme, 35, two counts of possession of a controlled substance, first offense and one count of possession of drug paraphernalia.
Civil Suits
June 19:
Liquidation Properties, Inc. vs. Diana J. Sizemore, Ronald Sizemore, Kentucky Tax Bill Servicing, Inc. and Commonwealth of Kentucky, Department of Revenue, Division of Collections, complaint & reformation of mortgage
Jonathan R. Hughes vs. Robin M. Hughes, petition for dissolution of marriage
Chrysler Financial Services Americas LLC vs. Douglas Smith and Teresa Smith, default of payment on note
June 22:
State Farm Mutual Automobile Insurance Company vs. Micah S. Lawson, seeking damages due to an auto accident
June 10
(Commissioner's Deed) Green Tree Servicing, LLC; Scott A. Smith and Peggy S. Smith, husband and wife; and Grant County Kentucky, by April Hollon Gatlin, Master Commissioner to Green Tree Servicing, LLC,
Latimer Lane property, $50,000
(Quit Claim Deed) Kathleen Guenther, Jean Ranz, Jaime Ranz, Paul F. Guenther, Susan J. Guenther, Jane Guenther-Oka and Thomas J. Oka to Kathleen Guenther and Jean Ranz, lot 2 of Foster Lake Subdivision, $46,000
Deputy Lee Jacobs investigated an accident at 6:20 p.m. on July 24 on N. Main in Crittenden. The drivers involved were April R. Bell, 20, of Dry Ridge, driving a 1994 Nissan, William L. Gross, 29, of Dry Ridge, driving a 1989 Ford and Brandon A. Epperson, 17, of Dry Ridge, driving a 2001 Dodge.
Deputy Kevin Burke investigated an accident at 4:16 p.m. on July 27 on Lebanon Road in Crittenden. The driver involved was Jerry Rigney, 67, of Crittenden, driving a 2001 Harley Davidson.
The Grant County grand jury, which met June 3 and July 15, returned indictments against 20 people.
Grant County Sheriff's Office
Deputy Brian Maines investigated an accident at 8:10 p.m. July 19 on Jonesville Road. The driver involved was Clara S. Gordon, 65, of Williamstown, driving a 2007 Chevrolet.
Deputy Brian Maines investigated an accident at 6:10 p.m. July 24 on U.S. 25 in Corinth. The drivers involved were Derrick W. Huff, 28, of Corinth, driving a 1994 Dodge and Dalina M. Bogan, 23, of Williamstown, driving a 2001 Chevrolet.
May 27:
(Special Warranty Deed) Federal National Mortgage Association to Bertha Gail Marshall, lot 224, Section 6 of the Harvesters, $80,900
May 28:
(Special Warranty Deed) Heritage Bank, Inc. to Kathy Coffey, lot 83, Section 2 of Eagle Creek Subdivision, $135,000
May 29:
Marion E. Hammonds and Lucille Hammonds, as Co-Trustees of the Trust Agreement and The Delaney Family Trust, by Betty Delaney, Trustee, Odella Delaney, Judy Atha, Robert Atha, husband and wife, Cordova Road property, $25,000
Copyright © 2018
The Grant County News is your source for local news, sports, events, and information in Dry Ridge, KY and the surrounding area.


text:
Meet thousands of Saint-Hilaire singles through one of the best St-Hilaire online dating sites. Matchmaker.com has great instant messenger and live video St-Hilaire chat service for our members. Saint-Hilaire dating has never been easier with our show interest feature that will allow you to break the ice with attractive local singles.
Matchmaker.com has some great services for St-Hilaire singles looking for a longer term relationship. Besides our great Saint-Hilaire chat product with live video matchmaker users can send email messages to people in the area. The Saint-Hilaire dating scene can be hard to find the right person at times; however, we are here to help and our St-Hilaire online dating service is free to register.
Saint-HilaireJoin Now Free!
St-Hilaire Girls | St-Hilaire Men | St-Hilaire Gay | St-Hilaire Lesbians
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
More Saint-Hilaire Links:
Saint-Hilaire Personals | Saint-Hilaire Speed Dating | Saint-Hilaire Chat | Saint-Hilaire Singles | Saint-Hilaire Love
Senior Dating | Catholic Dating | Christian Dating | Muslim Dating
Black Singles | Asian Singles | Latin Dating
Try our Saint-Hilaire dating service today. Matchmaker.com is one of the oldest Saint-Hilaire online dating services on the Internet and has brought thousands of couples together from the area. Test drive our Saint-Hilaire Chat room with one of the best online communities for the St-Hilaire single person. Also, keep in mind that we have a huge member base of Saint-Hilaire singles and that we also cater to members of the many backgrounds.
Still not convinced that matchmaker is the free St-Hilaire dating service for you? Once you've filled out the quick registration process you will be to see full size photos and profiles of thousands of Saint-Hilaire singles. Did you know that free St-Hilaire dating is a few clicks away? Find love and romance in Saint-Hilaire at matchmaker today!


text:
If you have any questions regarding the
rules and regulations of the Tennessee Registry of Election Finance, please
call (615) 741-7959. You may also link to the Tennessee Registry of Election Finance.
Click on the rule you want to view or print.
To print a rule, use the Print button located on the Acrobat Reader toolbar; be
sure to select the correct paper size in your print setup dialog box.
Keywords may be searched for in individual PDF files by using the
(Find) button located
on the Acrobat Reader toolbar.


text:
New Anti-HIV Drugs in Development
September 1999
A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!
Compared to previous years, advances in the field of HIV antiviral research today are few and far between. Only a handful of new drugs in development block HIV reproduction by new mechanisms. Most experimental anti-HIV drugs are simply improved versions of existing therapies or new variations of those currently available. Such therapies are likely to offer only incremental benefits in potency, simplified dosing and reduced side effects. Some will claim to be effective against anti-HIV drug resistant viruses based on laboratory tests, but it remains to be seen whether they will help people with highly resistant virus.
This article reviews the new anti-HIV drugs currently, or soon to be, in studies. We also note any attributes about each drug that may make it different (or not) from those currently available.
New Protease Inhibitors
ABT- 378: Abbott Laboratories' ABT-378 is furthest along in development of all the new protease inhibitors. This drug will be packaged with a small amount (100 to 200mg twice a day) of ritonavir (Norvir®), which significantly boosts and stabilizes ABT-378 levels in blood. Studies show that ABT-378 is very potent and well tolerated. Preliminary results show that people who had viral load increases after their first protease inhibitor-containing regimen experienced good responses to a combination of ABT-378 and nevirapine (Viramune®).
Laboratory studies show that ABT-378 has resistance patterns similar to those of currently available protease inhibitors. However, it is hoped that people will achieve such high levels of ABT-378 in the blood without toxicity that it will be able to overcome some of these protease inhibitor resistant viruses.
Preliminary results of using ABT-378 as part of a second line regimen (people who have failed only a single previous protease inhibitor regimen) were recently released and appeared quite positive. Seventy people with an average viral load of 10,000 copies HIV RNA and CD4+ cells counts of about participated in this study. While participants had not previously used a non-nucleoside reverse transcriptase inhibitor, most had previously used indinavir (Crixivan®) or nelfinavir (Viracept®) in combination with either AZT (zidovudine, Retrovir®) + 3TC (lamivudine, Epivir®) or d4T (stavudine, Zerit®) + 3TC. Almost everyone had developed resistance to 3TC and approximately half to AZT. Participants received 400mg of ABT-378 taken twice a day in combination with either 100mg or 200mg of ritonavir also taken twice a day for 14 days. At day 15, everyone added nevirapine (Viramune®) and at least one new nucleoside analogue reverse transcriptase inhibitor. See Drug ID Chart for a list of drug names and classes.
After 24 weeks, 77% of the participants had viral loads below 400 copies HIV RNA. There was also an average CD4+ cell count increase of 93 cells. More research is needed to determine if these results persist over time and whether the combination will be as successful when measured by the more demanding ultra-sensitive viral load test, which measures down to 50 copies of HIV RNA. Moreover, it is unknown if participants of the third line regimen studies will respond similarly to ABT-378.
Results of studies with ABT-378 for third line use (people who have lost sensitivity to two or more previous protease inhibitor regimens) have not yet been presented. Enrollment in these studies has been surprisingly slow and there are many available opportunities for people to access the drug through studies. For a list of study sites, call 1-800-TRIALSA. An expanded access program for ABT-378 began in early September. For more information on this program, see Expanded Access.
Tipranavir: Results were recently released of a laboratory study showing that tipranavir (formerly PNU-140690) remained sensitive to almost all of the protease inhibitor resistant viruses tested. Pharmacia and Upjohn, the developers of the drug, are planning several large studies that will include people who have not previously taken anti-HIV therapies as well as those seeking a third line regimen. It has been difficult to develop resistance to this drug in laboratory studies. However, this has been true for many other drugs only to later find that resistance can be developed quite readily in real life applications.
The initial formulation of the drug, which required people to take ten large pills three times a day, had slowed down the development process. Most people in the early studies developed diarrhea because of the `ingredients' in the pill as well as the number of pills that had to be taken. A new capsule formulation that allows for better drug absorption has recently been introduced. This new formulation should allow for twice a day dosing as well as a lower number of pills per day. Whether this solves the problem with diarrhea is unknown, but at least it makes the drug easier to use. Tipranavir is also being studied in combination with ritonavir, which significantly boosts tipranavir levels, and it is hoped that this combination will be useful for people who have developed resistance to the currently available protease inhibitors.
L-756,423: L-756,423 is Merck's new protease inhibitor. Laboratory studies suggest that the drug can be taken twice, or possibly once, a day with a reduced risk of developing kidney stones compared to Merck's other drug, Indinavir. This drug is being developed for use in a combination with indinavir (similar to ABT-378 and ritonavir). Laboratory studies show that the resistance pattern is similar other protease inhibitors so it's use in third line therapy is dubious.
DMP-450: DMP-450 is a protease inhibitor being developed by Triangle Pharmaceuticals. The drug is designed to be taken twice a day and has a similar resistance profile to other protease inhibitors. One possible advantage for this drug is that it is easier to manufacture and so, in theory may be less expensive.
BMS-232632: Bristol-Myers Squibb's first protease inhibitor, BMS-232632, is being studied in a once daily regimen. In some laboratory studies the drug develops the same resistance mutations as the currently available protease inhibitors, but in other experiments it appears to have a different resistance profile. Drugs which have shown similar conflicting results in the past have usually turned out to have problems with cross-resistance, like almost all other protease inhibitors.
Other New Protease Inhibitors: Parke Davis' PD 178390 and Agouron Pharmaceuticals' AG1776 appear to have different resistance profiles based on laboratory studies and the manufacturers claim they may be active against protease inhibitor resistant viruses. Both drugs are in early human studies. Again, past history with such claims suggests a cautious approach.
New Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Emivirine: The new NNRTI furthest along in development is Triangle Pharmaceuticals' emivirine (Coactinon®, formerly MKC-442). Triangle is expected to file for approval of this drug by the end of this year. Studies show that emivirine has the same resistance patterns as the other NNRTIs and most researchers believe that this drug will not offer any benefits for people who with NNRTI resistant virus. Emivirine is dosed twice a day and is quite well tolerated. Rash (perhaps at a much lower incidence than nevirapine) and gastrointestinal problems are the most commonly reported side effects.
Other New NNRTIs: There are many other NNRTIs in early development, most of which the developers claim to be at least somewhat active against viruses resistant to the currently approved NNRTIs, based on laboratory studies. These include Agouron Pharmaceuticals' AG1549, Glaxo Wellcome's GX420867X, Pharmacia and Upjohn's PNU142721, MediChem Sarawak's Calanolide A and Dupont Pharmaceuticals' DPC961 and DPC963. Time will tell if such claims are realistic.
New Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NARTIs and NtARTIs)
FTC: Almost all of the new NARTIs in development claim to be active against some viruses resistant to drugs of this class. The one exception is Triangle Pharmaceuticals' FTC (emtricitabine, Coviracil®). This drug is very similar to 3TC (lamivudine, Epivir®) and has the same resistance profile. FTC, however, does appear to be more potent than 3TC and only has to be dosed once a day. Like 3TC, FTC also has activity against hepatitis B virus.
Adefovir: Gilead Sciences recently applied for approval to the FDA for their NtARTI, adefovir (Preveon®). Study results show that the drug, which is dosed once a day, only has marginal anti-HIV activity but may play a role for people putting together a third line regimen. This drug appears to be especially active in the presence of 3TC resistance (and probably should be used in combination with 3TC even if someone has developed high level resistance to 3TC). Laboratory studies suggest that the drug is active against multi-NARTI resistant viruses. Despite this, the drug's activity level remains low.
Adefovir can seriously decrease L-carnitine levels, therefore supplemental L-carnitine should be taken with it. The side effects from this drug have been of great concern to many physicians. Increased serum creatinine levels (an indication of kidney dysfunction) and decreases in phosphate levels (an indication of decreased bone density) are of greatest concern. Furthermore, these side effects usually develop about 20 weeks after starting adefovir so people should be monitored more closely around that time.
Because of its somewhat unique mix of low activity levels and high risk of a potentially dangerous side effect, there is serious question whether the FDA will grant approval for adefovir. Were a similar drug with a similar mix of properties offered much earlier in the epidemic when there were fewer choices, approval would have seemed likely. But in the context of the 14 anti-HIV drugs already on the market, and with more in the wings, the outcome for adefovir is uncertain. It is further complicated by the fact that the manufacturer has a related and much more potent compound, PMPA, right behind it in the pipeline.
Due to the increased risks of side effects and the minimal anti-HIV activity observed with adefovir, AIDS Activists may not enthusiastically support FDA approval of this drug.
Based on early study results, adefovir also appears to have potent activity against hepatitis B virus including activity against 3TC resistant hepatitis B.
PMPA: Gilead Sciences is also developing another NtARTI, PMPA (tenofovir). Studies show this drug is significantly more potent against HIV than adefovir. PMPA is also dosed once a day. It is still unclear whether people taking PMPA will encounter the same side effects as those seen in people taking adefovir. Several third line studies are planned with PMPA in combination with other new anti-HIV therapies. Gilead announced an expanded access program for PMPA starting in October. For more information, refer to the box on expanded access.
Lodenosine: US Bioscience is developing lodenosine (formerly f-ddA). Laboratory studies suggest the drug may be effective against multi-NARTI resistant viruses. Lodenosine is being studied with twice a day dosing although it may be possible to take the drug once a day. Like ddI, adefovir and PMPA, lodenosine has a particularly potent interaction with hydroxyurea, an older cancer drug which is widely used in combination therapies.
Other NARTIs: Two other NARTIs -- BioChem Pharma's dOTC and Triangle Pharmaceuticals' DAPD -- are in early stage studies. Both Triangle and BioChem Pharma claim to have the rights to develop DAPD, although Triangle is the one sponsoring the ongoing studies. Both of these drugs may be effective against multi-NARTI resistant viruses.
New Targets
Pentafuside and T-1249: One drug that has received a lot of attention in the past few months is pentafuside (also known as T-20), which is being developed by Trimeris. Pentafuside belongs to a class of drugs known as fusion inhibitors, which work by physically blocking the ability of HIV to attach to CD4+ cells. Studies show that this drug is effective as a third line therapy, even in people who have become resistant to all current protease inhibitors. Getting a durable response, however, requires the drug to be paired with at least one other anti-HIV drug to which the person still responds. Pentafuside has to be administered via a subcutaneous (under the skin) injection twice a day and it will never be available in an oral formulation. Trimeris has also recently started studies with a second fusion inhibitor, T-1249. Laboratory studies suggest that this drug will be effective against T-20 resistant virus.
Other fusion inhibitors in development include Progenics' PRO 542 and Lexigen Pharmaceuticals' FP-21399. Development prospects for this particular drug have dimmed somewhat since the company ran out of money.
AMD-3100: AnorMED recently started development of their CXCR4 blocker, AMD-3100. The chemokine CXCR4 is one of the `pathways' that HIV uses to infect a new cell. This is the first chemokine blocker in development and if it proves successful, this drug may be particularly useful in people with advanced stage disease who have a particular type of HIV that reproduces very rapidly, known as syncitium inducing or SI type virus.
HE-2000: Hollis Eden recently started human studies with HE-2000. The exact way that this drug blocks HIV from reproducing has not been confirmed, although the company's current hypothesis is that it `starves' HIV of the essential proteins that it needs. HE-2000 is given by injection directly into the muscle. In laboratory studies, this drug is also said to have activity against numerous other viruses. The drug's main claim to legitimacy rests on a small, uncontrolled study in chimpanzees, where chimps were given HE- 2000 were reported to live somewhat longer than expected due to their SIV infection.
On the Horizon
Several companies including Merck, Pfizer and Bristol-Myers Squibb are developing blockers against the CCR5 chemokine receptor. CCR5 is another `pathway' that HIV uses to infect new cells. If this strategy proves successful, these CCR5 blockers may be useful in people with early stage HIV disease who have a type of virus known as non-syncitium inducing or NSI virus. Given that HIV can infect cells through many different pathways, it may be necessary to combine a CCR5 and CXCR4 blocker to prevent HIV from infecting new cells. Because this is a completely new field of drug development, it is likely to take a number of years before truly effective drug candidates will be found.
A few years ago there was a tremendous amount of interest in research around inhibitors of the integrase enzyme. Integrase is another one of the essential enzymes that HIV uses to make new infectious viruses. However, a lot of the enthusiasm has been dampened as companies have failed to come up with potent drugs against this target. One company that may be close to selecting a drug for development is Merck. They have reported on different integrase inhibitors that in laboratory studies are potent inhibitors of HIV. One barrier that they face is that the drugs bind to proteins found in the human body before they have a chance to become active against the virus. Though this probably effects most of the available protease inhibitors as well, Merck was able to overcome this problem with indinavir. Thus there is hope they will be able to do this again.
While this may seem like a reasonable number of new drugs in the pipeline, their potential is limited by the fact that few if any are likely to be active against highly resistant virus, where the need is greatest. There are already many viable options for first line therapy, and reasonable, improving options for second line therapy. The new crop of drugs offers only incremental advances over these options, such as once-daily dosing. The greater challenge, finding drugs that will be highly potent despite multi-drug resistant virus, remains largely unmet, with the one proven exception of T-20.
A note from TheBody.com: The field of medicine is constantly evolving. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!
This article was provided by Project Inform. It is a part of the publication Project Inform Perspective. Visit Project Inform's website to find out more about their activities, publications and services.


text:
Heroism and honor over German skies
Cross posted.
Last week my Kindle went to the great Kindle Outlet Store in the sky. Apparently it fell out of my pocket and I ran over it with the car. In Kindle heaven it will no doubt meet its two predecessors; the one I rolled over on top of on a camping trip and the one I left on an airplane. This caused much consternation in my house, because I read about 3 books a week and is my chief means of coping with stress.
As I sat at my desk lamenting my loss, my friend Emory sent me a link to a remarkable story about a US Air Force bomber pilot during WWII that got shot up REALLY bad, but then a german fighter pilot escorted him through the anti aircraft areas and out over the North Sea on his return to England. It was a remarkable story, and I enjoyed it very much.
A few hours later I got an email from a administrative assistant to my Editor who had just fielded a call from a guy who had given her the brief outline of the same story and asked if I knew anything about it. I said that remarkably I did, and sent her the same link that Emory had sent me. Twenty minutes later she walked into my office smiling and handed me a copy of Adam Makos' book "A Higher Call: An Incredible True Story Of Combat And Chivalry In The War-Torn Skies Of World War II."
Had my kindle not have been broken, I very likely wouldn't have read the book. We get hundreds of books sent here every month, and with a few exceptions, I don't read much in the way of war stories anymore. But, it was quite fortuitous on the timing, so on Friday night I started reading it.
Mr. Makos had me pretty well hooked right in his opening paragraph in the introduction:
On December 20, 1943, in the midst of World War II, an era of pain, death, and sadness, an act of peace and nobility unfolded in the skies over Northern Germany. An American bomber crew was limping home in their badly damaged B-17 after bombing Germany. A German fighter pilot in his Bf-109 fighter encountered them. They were enemies, sworn to shoot one another from the sky. Yet what transpired between the fighter pilot and the bomber crewmen that day, and how the story played out decades later, defies imagination. It had never happened before and it has not happened since. What occurred, in most general terms, may well be one of the most remarkable stories in the history of warfare.
As remarkable as it is, it's a story I never wanted to tell.
Mr Makos went on to talk about how as a young WWII history enthusiast he had grown up believing that WWII was nothing less than the good guys (us) against the bad guys (the Germans or "Nazis".) But as he researched this book and spoke with Charlie Brown, the pilot of the B-17, Charlie said something that would change the story: "In this story," Charlie said, "I'm just a character – Franz Stigler is the real hero."
Franz was the pilot of the Bf-109, and in reading the book, you see that the good/bad dichotomy really doesn't work. The US were certainly the good guys, and the Nazi's (and assorted Gestapo and other "Party" individuals) were definitely the bad guys, but the German Pilots themselves don't fall into the latter category. The honor that some of these guys showed will astound some readers.
German Pilots were very supportive to the American Pilots they shot down. In fact, often German Pilots would race to where the American pilots jumped or crashed, and take them into custody themselves to ensure that they would be placed in Luftwaffe facilities and not in "Party" ones or other POW camps. One pilot in particular, Hans-Joachim Marseille flew with Franz in Africa and had impressed upon Franz the inherent honorable nature of what was expected from German pilots.
One part of the book discusses this at some length.
…The legend went that Marseille had shot down a British pilot named Byers, who had been badly burned when captured. Marseille personally took Byers to the field hospital, where hospital staff told Marseille the prisoner's name and unit. That evening, Marseille flew through British flak to drop a note over Byers's airfield, addressed to his comrades. The note said that Byers was badly wounded but was being cared for. Two weeks later, when Byers died of his wounds, Marseille felt so badly that he flew back through the flak to the British field and dropped another note notifying Byers's friends and sending deepest regrets. It was a gallant act that earned the respect of many in the Air Force except for one: the second most powerful man in The Party, who doubled as the Air Force's leader – Reichsmarschall Hermann Goering. Goering had once been an ace in the Red Baron's squadron in WWI but had since become known throughout the Air Force with disdain. Someone had nicknamed Goering "the Fat One," due to his heft, and it had stuck. Goering put out an edict that no pilot should ever again attempt a stunt like the one Marseille had.
"Is the story true?" Franz said to Marseille.
Schroer nodded slightly, for only Franz to see.
There was another portion of the book that talked about German Ace Günther Lützow:
…Luetzow had been the commander of Fighter Wing 3 (JG-3) on an airfield outside of Kharkov in the Ukraine, when SS soldiers came to commandeer his services. They wanted Luetzow to lend them any non-flyers he could spare to help them round up people they called "undesirables." Luetzow knew the reputation of the SS and knew that whatever they were planning, it could not be good. When Luetzow refused to help them, the SS threatened to go around him. Luetzow called his entire wing to the tarmac in dress uniform – the pilots, the orderlies, and even the mechanics. Luetzow told them what the SS had asked of him and said he would remove his Knight's Cross and resign from the Air Force if any of his men complied with the SS's request.
Even as German and US (and other nations) air forces fought over the European skies, what struck me as most interesting was the fight between the honorable men of the German Luftwaffe with their German leadership.
The meeting of Charlie and Franz over Germany is just a small part of the book, but it is the tie that binds these two wonderful men. As I read through the book I did what I normally do when I really enjoy a book: I contacted the author and told him how much I enjoyed it. I've read some outstanding books in the past year, and this is certainly in the top echelon of those books. (With "The Outpost" by Jake Tapper, and the phenomenal "Road to Valor" by Ali McConnon which talks about an Italian Cyclist's heroism during WWII.)
Mr. Makos friended me on Facebook and had this to say:
I hope [my book] makes Franz and Charlie household names like Band of Brothers did for Dick Winters and Buck Compton and Don Malarkey
Indeed. And I also hope it allows folks to see that even amidst the atrocities that comes with war, that some people, even our enemies, are capable of honorable acts of heroism.
I hope you will pick up a copy of "A Higher Call" and enjoy it as much as I did. You can purchase it at AMAZON, at this link.
Category: Politics


text:
Cotton and soybean farmers can add another worry to the long list of things that give them pause about the Doha Development Round negotiations that many expect to kick off again this fall.
This "new" wrinkle — product-specific spending caps — actually dates back to the Doha Round Framework Agreement that WTO ministers approved in July 2004. But not much has been said about it publicly, according to Mark Lange, president and CEO of the National Cotton Council.
"The G-20 developing countries and the European Union proposed using a 1995-2000 average for the support measures for the major commodities during that period," he said. "The United States has been proposing 1999-2001. Unfortunately, not many people support the U.S. time period, but there are a lot of folks lining up behind the other.
"And it's very clear that the 1995-2000 time period results in lower caps for all U.S. commodities, but significantly lower caps for cotton and soybeans."
Speaking at the joint summer meeting of the ACP and The Cotton Foundation in San Antonio earlier this month, Lange said the U.S.-supported average for cotton would provide a $2.07 billion spending cap vs. $806 million for the 1995-2000 average and $3.36 billion vs. $1.3 billion for soybeans.
Another element of concern is the amount of support calculated for the dairy and sugar programs in the so-called aggregate measures of support or amber box category of farm programs.
Last October, the Bush administration proposed a 60-percent reduction in AMS or amber box support and a 53-percent reduction in Trade Distorting Domestic Support to try to help get the Doha Round over another hurdle that threatened to deadlock the negotiations.
The proposal would reduce the current amber box ceiling on those aggregate measures of support — marketing loan gains, dairy, sugar, loan forfeitures and interest subsidies — from $19.1 billion to $7.64 billion. Total TDDS would drop from $47.74 billion to $21.96 billion.
"Dairy and sugar annually don't cost a lot of money, but they do run programs that, under the WTO rules, have to be estimated as to the producer subsidy equivalents that are generated by the nature of the programs," said Lange. "For dairy, that will commonly run in excess of $4.5 billion and for sugar in excess of $1 billion.
"They are measures of support although they do not involve direct spending by the government, and they have to be part of the $19.1 billion amber box ceiling.
Lange noted the proposed amber box ceiling of $7.64 billion is a very real constraint. "We estimate that with the exception of 2003, every year since 1997 the United States would have exceeded the new proposed ceiling. All commodity programs will be impacted by the lower cap."
He said members of the audience of leaders of the state cotton producer organizations and the allied industry members who belong to The Cotton Foundation have probably heard the calls for the U.S. government to offer to make further cuts in its farm programs to appease other members of the WTO.
Agriculture groups, including the National Cotton Council and other members of the "Gang of 11" farm groups, have repeatedly told the U.S. Trade Representative, Susan Schwab, that they will not support any more reductions in U.S. domestic subsidies.
The U.S. Trade Representative has held firm to the U.S. position during the agricultural negotiations. The significant market access gains sought in the U.S. agricultural proposal are necessary in order to offset the type of reductions in domestic support outlined by Lange. This points to the market access debate as the focal point in any renewed negotiations.
"All of this hinges on the WTO negotiators reaching an agreement this fall or in 2007," says Lange. "If there is no Doha agreement, then these don't matter.
e-mail: [email protected]


text:
Study break
Health studies tell us what's good and what's bad for us — and they also seem to change as quickly as the weather and which Bieber song is playing on the radio.
Take eggs, wine and coffee: Just as we're celebrating their health benefits with a daily omelet or clink of our wine glass, another study comes out warning of potential harm.
What gives?
Ann Zeeh, the department chairwoman of physical and biological sciences and an associate professor of biology at The College of Saint Rose, says we may never have set-in-stone answers.
Studies come out almost daily, performed in a controlled laboratory with genetically identical animals that show whether a food is good or bad for the specimens.
There are two problems when studies are done strictly on genetically identical animals, Zeeh says. First, something may react differently in humans than it does in animals. Case in point — chocolate. The cocoa sweetness is a savory treat for humans and a toxic nightmare for man's best friend.
Second, no two humans are the same. "When studies are done in people, you can't find a group of genetically identical people to work on. They each have their own genetic makeup and lifestyle," Zeeh says.
More Information
July 1989, GOOD: The U.S. Department of Agriculture reports eggs produced in 1989 have 22 percent less cholesterol than their counterparts in 1976. The American Heart Association raises the recommended weekly egg consumption from three to four.
November 2008, BAD: Harvard Medical School links a daily egg with premature death. The report found that subjects who ate more than seven eggs a week were 23 percent more likely to have died during the test period of more than 20 years.
January 2009, GOOD: Two University of Alberta scientists find certain egg proteins are surprisingly similar to prescription drugs used to treat high blood pressure, despite their high cholesterol content.
June 2010, GOOD: Contrary to what is previously believed — and their own 2008 report — a Harvard Medical School study determines that as long as adults don't eat more than seven eggs a week, they are not at an increased risk of developing Type 2 diabetes.
November 2010, BAD: A report in the Canadian Journal of Cardiology says one egg yolk contains as much cholesterol as a KFC Double Down sandwich (bacon, two kinds of cheese and the Colonel's secret sauce between two Original Recipe chicken fillets).
October 2011, BAD: California researchers study 27,607 men over 14 years and determine egg consumption "may increase risk of developing a lethal form of prostate cancer among healthy men." Researchers find those who eat more than 2.5 eggs per week have an 81 percent increased risk of dying from prostate cancer.
August 2012, BAD: New research finds a link between eating eggs and high levels of the artery-clogger, carotid, which causes heart attacks and strokes.
April 2013, GOOD: Yale University research finds whole eggs can be a part of a heart-healthy diet. Even for those with coronary heart disease, the protein-packed egg can still be healthy.
CONCLUSION, GOOD: "Eggs are one of those perfect foods," McCue says. One of the biggest misconceptions with eggs is their cholesterol value. While the eggs contain cholesterol, it isn't the same cholesterol that affects your blood.
March 1981, BAD: The Harvard School of Public Health finds a link between drinking coffee and cancer of the pancreas.
July 2005, GOOD: Researchers find higher coffee consumption may reduce the risk of Type 2 diabetes. Those who drank more than five to seven cups a day were 35 percent less likely to have Type 2 diabetes than those who drank less than two cups per day.
December 2008, BAD: A report in the Federation of American Societies for Experimental Biology states one dose of caffeine (two cups of coffee) during pregnancy may be enough to affect fetal heart development and reduce heart function over the lifespan of the child.
January 2009, GOOD: Finnish and Swedish researchers find those who reported drinking three to five cups of coffee per day were 65 percent less likely to develop dementia and Alzheimer's disease.
February 2009, GOOD: A long-term Nurses' Health Study shows a 20 percent lower risk of stroke in those who reported drinking two or more cups of coffee per day compared to those who drank less or none at all.
March 2010, GOOD: Kaiser Permanente Division of Research researchers find those who reported drinking four or more cups of coffee per day had an 18 percent lower risk of hospitalization for heart rhythm disturbances.
May 2011, GOOD: Harvard School of Public Health researchers find men who consumed one to three cups of coffee per day were associated with a 30 percent lower risk of lethal prostate cancer.
May 2013, BAD: Mice given an equivalent dose of five cups of coffee developed twice the amount of visceral fat, according to Australian researchers. This type of fat is the most dangerous form that collects around the organs and abdomen.
Conclusion, GOOD: As long as a person isn't drinking coffee for self-medication and doesn't have pre-existing conditions caffeine may alter, coffee can be beneficial, McCue says. She recommends buying organic or fair-trade coffee.
April 1988, BAD: The University of Texas Southwestern Medical Center reports wine makes the stomach secrete excess acid, unlike hard liquor.
December 1994, BAD: Heavy alcohol consumption raised overall death rates and the rates of death from other causes, especially cirrhosis of the liver, researchers at the University of California at San Diego find.
May 1995, GOOD: Danish researchers say those studied between the ages of 30 and 70 who drank wine daily were much less likely to die during the study period than those who didn't. A 49 percent reduction in mortality was associated with drinking three to five glasses of wine a day.
January 1997, GOOD: Researchers at the University of Illinois suggest resveratrol, a substance found in the skin of grapes, may interfere with the development of cancer. The substance does this by blocking the action of carcinogens, inhibiting the initiation and promotion of tumors and causing precancerous calls to revert to normal.
December 1998, GOOD: Those who said they drank about one to six glasses of wine per week had a 34 percent lower risk of stroke than those who didn't drink wine, Danish researchers find.
September 2007, BAD: In one of the largest studies on the effects of alcohol, researchers discover the substance, no matter the form, increases the risk of breast cancer. The increased risk from drinking three or more alcoholic drinks per day is similar to the increased risk from smoking a pack of cigarettes or more a day.
June 2008, GOOD: Resveratrol, the substance found in the skin of grapes, reduces the number of fat cells and may one day be used to treat or prevent obesity.
November 2008, GOOD: Polyphenols, naturally occurring compounds in red wine, block the formation of proteins that build the toxic plaques thought to destroy brain cells.
Conclusion, GOOD and BAD: Many mass-manufactured wines contain chemical additives, which may override wine's perks, McCue says. But there can be overall benefits to a little vino.
Mary Beth McCue, an integrative and functional medicine registered dietitian at Saratoga Nutrition, says there is no definite answer on the healthiness of our beloved eggs, wine and coffee because some people suffer from conditions others may not.
And, Zeeh says, "The nature of science is that it's always changing. Few studies figure out something that is perfect for all time."
firstname.lastname@example.com • 518-454-5028


text:
WASHINGTON (AP) — House Speaker John Boehner is demanding the White House and congressional Democrats negotiate with congressional Republicans about ways to re-open the government and address criticisms of the president's health care law.
Boehner told reporters Friday: "This isn't some damn game." He said House Republicans still want "fairness to the American people" under the program critics call "Obamacare."
President Barack Obama has refused GOP efforts to delay a major element of the health law enacted in 2010.
House Republican Whip Kevin McCarthy says Obama's decision to cancel an Asia trip offers the "perfect opportunity to begin negotiations."
Democrats say they will negotiate budget matters with Republicans, but they will not alter the health care law.